Joshua Pinto, President at Neumora Therapeutics, Inc. (NMRA), sold 8,048 shares at $1.67 ($13K) on 2025-02-18, disclosed to the SEC on 2025-02-20.
Scheduled sale ($13k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NMRA | SELL | 2024-08-26 | $2.0M | — | Filing → |